ID
35161
Beschreibung
Study ID: 107495 Clinical Study ID: 107495 Study Title: A phase II, open, randomized study in adults aged between 18 and 60 years designed to evaluate the reactogenicity and immunogenicity of a 1- and 2-dose prime-boost concept of pandemic monovalent (H5N1) influenza vaccine (split virus formulation) adjuvanted with AS03, administered according to different vaccination schedules. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00430521 https://clinicaltrials.gov/ct2/show/NCT00430521 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Pandemic influenza vaccine (GSK1119711A)-formulation 1, Pandemic influenza vaccine (GSK1119711A)-formulation 2 Trade Name: N/A Study Indication: Influenza There are 4 workbooks (WB): WB 1: Protocol 107495, (H5N1-012), Groups: VT/VT/6Mo, VT/IN/6Mo WB 2: Protocol 107495, (H5N1-012), Groups: VT/VT/12Mo, VT/IN/12Mo WB 3: Protocol 107495 (H5N1-012) GROUPS: 2VT/VT/6MO, 2VT/IN/6MO WB 4: Protocol 107495 (H5N1-012) Groups: 2VT/VT/12Mo, 2VT/IN/12Mo Every Workbook has the following visits: Visit Day 0 (Screening, Dose 1), Visit Day 21, Visit Month 6, Visit Month 12 and Visit Month 18. After Month 6 (+30 days, if applicable) and Month 12 (+30 days, if applicable) there is a Core Analysis section, followed by a final study conclusion after Month 18. Workbook 1 schedules a vaccination at screening and Month 6 each, Workbook 2 at Screening and Month 12. 30 days after the first vaccination there is an additional telephone contact. After the second vaccination additional visits/contacts are necessary in both workbooks: a visit at Month 6/12 + 7 and 21 days and a telephone contact on Month 6/12 + 30 days. Workbook 3 schedules a vaccination at screening, Day 21 and Month 6 and Workbook 4 at screening, Day 21 and Month 12. After the second vaccination there is an additional visit on Day 42 and a telephone contact on day 51. After the third vaccination there are additional visits/contacts: visits at Month 6/12 + 7 and 21 days and a telephone contact at Month 6/12 + 30 days. After Month 6 (+30 days, if applicable) and Month 12 (+30 days, if applicable) there is a Core Analysis section. This document contains the Solicited adverse events - local and general symptoms and Unsolicited AE form. It has to be filled in for screening for all workbooks (WB1-4). It also has to be filled in for: WB 1: Visit Month 6 WB 2: Visit Month 12 WB 3: Visit Day 21 and Visit Month 6 WB 4: Visit Day 21 and Visit Month 12
Link
https://clinicaltrials.gov/ct2/show/NCT00430521
Stichworte
Versionen (2)
- 18.02.19 18.02.19 -
- 20.02.19 20.02.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
20. Februar 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Evaluation of reactogenicity and immunogenicity of pandemic monovalent (H5N1) influenza vaccine in adults, NCT00430521
Solicited adverse events - local and general symptoms, Unsolicited AE
Beschreibung
Solicited adverse events - local symptoms
Alias
- UMLS CUI-1
- C1457887
- UMLS CUI-2
- C0205276
- UMLS CUI-3
- C0042196
Beschreibung
Signs/symptoms after vaccination
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0037088
- UMLS CUI [1,2]
- C0042196
Beschreibung
Local Symptoms
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C0205276
Beschreibung
Please tick No/Yes for each symptom
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C0150312
Beschreibung
Day of symptom
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0439228
- UMLS CUI [1,2]
- C1457887
Beschreibung
Note for: Redness, Swelling, Ecchymosis and Induration
Datentyp
integer
Maßeinheiten
- mm
Alias
- UMLS CUI [1,1]
- C0456389
- UMLS CUI [1,2]
- C0518690
Beschreibung
Intensity of symptom
Datentyp
integer
Alias
- UMLS CUI [1]
- C0518690
Beschreibung
Symptom's ongoing
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0549178
- UMLS CUI [1,2]
- C1457887
Beschreibung
day month year
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C1457887
Beschreibung
Medically attended visit
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C1386497
Beschreibung
Type of medically attended visit
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C0332307
- UMLS CUI [1,3]
- C1386497
Beschreibung
Solicited adverse events - general symptoms
Alias
- UMLS CUI-1
- C0159028
- UMLS CUI-2
- C0042196
Beschreibung
Signs/symptoms after vaccination
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0037088
- UMLS CUI [1,2]
- C0042196
Beschreibung
General symptoms
Datentyp
text
Alias
- UMLS CUI [1]
- C0159028
Beschreibung
Please tick No/Yes for each symptom
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1457887
- UMLS CUI [1,2]
- C0150312
Beschreibung
Day of symptom
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0439228
- UMLS CUI [1,2]
- C1457887
Beschreibung
Measurement of body temperature
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0886414
- UMLS CUI [1,2]
- C0449444
Beschreibung
Definition of Fever: Axillary >= 37.5°C, Oral >= 37.5°C, Rectal >= 38° C
Datentyp
float
Maßeinheiten
- °C
Alias
- UMLS CUI [1]
- C0005903
Beschreibung
Body temperature not taken
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0437722
Beschreibung
For Fatigue, Headache, Myalgia, Shivering, Arthralgia, Sweating increase
Datentyp
integer
Alias
- UMLS CUI [1]
- C0518690
Beschreibung
Symptom's ongoing
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0549178
- UMLS CUI [1,2]
- C1457887
Beschreibung
day month year
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C1457887
Beschreibung
Causality of symptoms
Datentyp
text
Alias
- UMLS CUI [1]
- C0015127
Beschreibung
Medically attended visit
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C1386497
Beschreibung
Type of medically attended visit
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0545082
- UMLS CUI [1,2]
- C0332307
- UMLS CUI [1,3]
- C1386497
Beschreibung
Unsolicited Adverse events
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C0042196
Beschreibung
If you tick yes, please fill in the Non-Serious Adverse Event section or Serious Adverse Event report, as appropriate. Time specification: For WB1: 1) between Visit Day 0 and Telephone contact Day 30, 2) between Visit Month 6 and Telephone contact Month 6 + 30 days. For WB2: 1) between Visit Day 0 and Telephone contact Day 30, 2) between Visit Month 12 and Telephone contact Month 12 + 30 days. For WB3: 1) between Visit Day 0 and Visit Day 21, 2) between Visit Day 21 and Telephone contact Day 51, 3) between Visit Month 6 and Telephone contact Month 6 + 30 days. For WB4: 1) between Visit Day 0 and Visit Day 21, 2) between Visit Day 21 and Telephone contact Day 51, 3) between Visit Month 12 and Telephone contact Month 12 + 30 days.
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0042196
- UMLS CUI [1,2]
- C0877248
- UMLS CUI [1,3]
- C4055646
Ähnliche Modelle
Solicited adverse events - local and general symptoms, Unsolicited AE
C0205276 (UMLS CUI-2)
C0042196 (UMLS CUI-3)
C0042196 (UMLS CUI [1,2])
C0150312 (UMLS CUI [1,2])
C0518690 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,3])
C1386497 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,2])
C1386497 (UMLS CUI [1,3])
C0042196 (UMLS CUI-2)
C0042196 (UMLS CUI [1,2])
C0150312 (UMLS CUI [1,2])
C0449444 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C1457887 (UMLS CUI [1,3])
C1386497 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,2])
C1386497 (UMLS CUI [1,3])
C0042196 (UMLS CUI-2)
C0877248 (UMLS CUI [1,2])
C4055646 (UMLS CUI [1,3])